|
|
||||||||





* Department of Molecular Biology and Biochemistry, and Center for Immunology, University of California, Irvine, CA 92697;
Immunoregulation Unit, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health, Bethesda, MD 20892;
Molecular Immunology and Inflammation Branch, NIAMS, National Institutes of Health, Bethesda, MD 20892; and
Division of Hematology/Oncology, Department of Medicine, College of Medicine, University of California, Irvine, CA 92697
Fas-associated death domain protein (FADD) constitutes an essential component of TNFR-induced apoptotic signaling. Paradoxically, FADD has also been shown to be crucial for lymphocyte development and activation. In this study, we report that FADD is necessary for long-term maintenance of S6 kinase (S6K) activity. S6 phosphorylation at serines 240 and 244 was only observed after long-term stimulation of wild-type cells, roughly corresponding to the time before S-phase entry, and was poorly induced in T cells expressing a dominantly interfering form of FADD (FADDdd), viral FLIP, or possessing a deficiency in caspase-8. Defects in S6K1 phosphorylation were also observed. However, defective S6K1 phosphorylation was not a consequence of a wholesale defect in mammalian target of rapamycin function, because 4E-BP1 phosphorylation following T cell activation was unaffected by FADDdd expression. Although cyclin D3 up-regulation and retinoblastoma hypophosphorylation occurred normally in FADDdd T cells, cyclin E expression and cyclin-dependent kinase 2 activation were markedly impaired in FADDdd T cells. These results demonstrate that a FADD/caspase-8-signaling axis promotes T cell cycle progression and sustained S6K activity.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by National Institutes of Health Grant AI050606 (to C.M.W.) and Training Grants T32GM007311, T32CA09054, and T32AI060573 (to A.F.A., B.D.B., and S.J.R., respectively).
2 Current address: Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.
3 Address correspondence and reprint requests to Dr. Craig M. Walsh, Department of Molecular Biology and Biochemistry, and Center for Immunology, University of California, Irvine, CA 92697-3900. E-mail address: cwalsh{at}uci.edu
4 Abbreviations used in this paper: FADD, Fas-associated death domain protein; DD, death domain protein; FADDdd, dominant-negative form of FADD; v-FLIP, viral FLIP; S6K, S6 kinase; CDK, cyclin-dependent kinase; Rap, rapamycin; mTOR, mammalian target of Rap; Rb, retinoblastoma; Rosc, roscovitine; ChIP, chromatin immunoprecipitation; 7AAD, 7-aminoactinomycin D; SGK, serum and glucocorticoid-regulated kinase.
This article has been cited by other articles:
![]() |
N. Kurabe, S. Arai, A. Nishijima, N. Kubota, F. Suizu, M. Mori, J. Kurokawa, M. Kondo-Miyazaki, T. Ide, K. Murakami, et al. The Death Effector Domain-containing DEDD Supports S6K1 Activity via Preventing Cdk1-dependent Inhibitory Phosphorylation J. Biol. Chem., February 20, 2009; 284(8): 5050 - 5055. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Ch'en, D. R. Beisner, A. Degterev, C. Lynch, J. Yuan, A. Hoffmann, and S. M. Hedrick Antigen-mediated T cell expansion regulated by parallel pathways of death PNAS, November 11, 2008; 105(45): 17463 - 17468. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Bell, S. Leverrier, B. M. Weist, R. H. Newton, A. F. Arechiga, K. A. Luhrs, N. S. Morrissette, and C. M. Walsh FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells PNAS, October 28, 2008; 105(43): 16677 - 16682. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Barbero, D. Barila, A. Mielgo, V. Stagni, K. Clair, and D. Stupack Identification of a Critical Tyrosine Residue in Caspase 8 That Promotes Cell Migration J. Biol. Chem., May 9, 2008; 283(19): 13031 - 13034. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |